Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 11, Pages 2833
Publisher
MDPI AG
Online
2021-06-08
DOI
10.3390/cancers13112833
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
- (2020) Irina Larionova et al. Frontiers in Oncology
- Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases
- (2019) In Jun Yeo et al. PHARMACOLOGY & THERAPEUTICS
- Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies
- (2019) Bingxian Bian et al. Cancer Cell International
- Is Delayed Time to Surgery Associated with Increased Short-term Complications in Patients with Pathologic Hip Fractures?
- (2019) Nathan H. Varady et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- An Easy-to-Use Prognostic Model for Survival Estimation for Patients with Symptomatic Long Bone Metastases
- (2018) J.J. Willeumier et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer
- (2018) Noomi Vainer et al. Oncotarget
- Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein
- (2017) Yulei Chen et al. Journal of Hematology & Oncology
- Prognostic value of biochemical variables for survival after surgery for metastatic bone disease of the extremities
- (2016) Michala Skovlund Sørensen et al. JOURNAL OF SURGICAL ONCOLOGY
- Extent of Surgery Does Not Influence 30-Day Mortality in Surgery for Metastatic Bone Disease
- (2016) Michala Skovlund Sørensen et al. MEDICINE
- Prediction of survival after surgery due to skeletal metastases in the extremities
- (2016) M. S. Sørensen et al. Bone & Joint Journal
- YKL-40/CHI3L1 drives inflammation on the road of tumor progression
- (2015) Stephania Libreros et al. JOURNAL OF LEUKOCYTE BIOLOGY
- From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation
- (2014) Martin Pal et al. IMMUNOLOGY AND CELL BIOLOGY
- New prognostic factors and scoring system for patients with skeletal metastasis
- (2014) Hirohisa Katagiri et al. Cancer Medicine
- Trends in the Surgical Treatment of Pathologic Proximal Femur Fractures Among Musculoskeletal Tumor Society Members
- (2012) Matthew Steensma et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Treating Metastatic Disease: Which Survival Model Is Best Suited for the Clinic?
- (2012) Jonathan Agner Forsberg et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Plasma YKL-40 levels in healthy subjects from the general population
- (2011) Stig E. Bojesen et al. CLINICA CHIMICA ACTA
- Plasma YKL-40: a potential new cancer biomarker?
- (2009) Julia S Johansen et al. Future Oncology
- Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis
- (2008) Lene S. Knudsen et al. BIOMARKERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now